AbbVie Capacity Update July 2024: Large Molecule Development
In this presentation from the July 2024 OPCU event, AbbVie CMO delves into the intricacies of biopharmaceutical manufacturing, focusing on the synthesis of biologically derived Active Pharmaceutical Ingredients (APIs). The discussion encompasses various stages such as cell line development, fermentation, and advanced purification methods. We also explore process optimization and scale-up techniques essential for fulfilling production demands while maintaining strict quality standards. Additionally, the presentation highlights rigorous quality control measures integral to biopharmaceutical production, setting the foundation for the development of innovative biologic therapies.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.